Tenofovir vs. Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma after Radiofrequency Ablation

Tenofovir vs. Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma after Radiofrequency Ablation

For patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) treated with curative radiofrequency ablation (RFA), the effect of entecavir (ETV) vs. tenofovir disoproxil fumarate (TDF) on recurrence-free survival (RFS) and overall survival (OS) remains unclear. We aimed to compare...

Full description

Bibliographic Details
Main Authors: Zili Hu, Huilan Zeng, Jingyu Hou, Juncheng Wang, Li Xu, Yaojun Zhang, Minshan Chen, Zhongguo Zhou
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Viruses
Subjects:
hepatocellular carcinoma
chronic hepatitis B
entecavir
tenofovir disoproxil fumarate
comparative effectiveness
Online Access:https://www.mdpi.com/1999-4915/14/4/656

Similar Items

Similar Items